Literature DB >> 23559581

Association between younger age when first overweight and increased risk for CKD.

Richard J Silverwood1, Mary Pierce, Claudia Thomas, Rebecca Hardy, Charles Ferro, Naveed Sattar, Peter Whincup, Caroline Savage, Diana Kuh, Dorothea Nitsch.   

Abstract

There is little information on how the duration of overweight or obesity during life affects the risk for CKD. To investigate whether prolonged exposure to overweight during adult life increases the risk of later CKD in a cumulative manner, we analyzed data from the Medical Research Council National Survey of Health and Development, a socially stratified sample of 5362 singleton children born in 1 week in March 1946 in England, Scotland, and Wales. Multiple imputation expanded the analysis sample from the initial 1794 participants with complete data to 4584. This study collected self-reported body mass index (BMI) at ages 20 and 26 years and measured BMI at ages 36, 43, 53, and 60-64 years. The outcome of interest was CKD at age 60-64 years, suggested by estimated GFR (eGFR) <60 ml/min per 1.73 m(2) and/or urine albumin-to-creatinine ratio (UACR) ≥ 3.5 mg/mmol. In analyses adjusted for childhood and adulthood social class, first becoming overweight at younger ages was associated with higher odds of developing CKD by age 60-64 years. Compared with those who first became overweight at age 60-64 years or never became overweight, those first overweight at age 26 or 36 years had approximately double the odds of developing CKD. The strength of this association decreased with increasing age when first overweight (P for trend <0.001). These associations were consistent for creatinine-based eGFR, cystatin C-based eGFR, and UACR. Taken together, these results suggest that preventing overweight in early adulthood may have a considerable effect on the prevalence of CKD in the population.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23559581      PMCID: PMC3636792          DOI: 10.1681/ASN.2012070675

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  33 in total

1.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.

Authors: 
Journal:  Am J Kidney Dis       Date:  2002-02       Impact factor: 8.860

2.  The life course prospective design: an example of benefits and problems associated with study longevity.

Authors:  M E J Wadsworth; S L Butterworth; R J Hardy; D J Kuh; M Richards; C Langenberg; W S Hilder; M Connor
Journal:  Soc Sci Med       Date:  2003-12       Impact factor: 4.634

3.  Prevalence of renal impairment and its association with cardiovascular risk factors in a general population: results of the Swiss SAPALDIA study.

Authors:  Dorothea Nitsch; Denise Felber Dietrich; Arnold von Eckardstein; Jean-Michel Gaspoz; Sara H Downs; Philippe Leuenberger; Jean-Marie Tschopp; Otto Brändli; Roland Keller; Margaret W Gerbase; Nicole M Probst-Hensch; Elisabeth Zemp Stutz; Ursula Ackermann-Liebrich
Journal:  Nephrol Dial Transplant       Date:  2006-01-03       Impact factor: 5.992

4.  Use and misuse of population attributable fractions.

Authors:  B Rockhill; B Newman; C Weinberg
Journal:  Am J Public Health       Date:  1998-01       Impact factor: 9.308

5.  Population heterogeneity in trajectories of midlife blood pressure.

Authors:  Andrew K Wills; Debbie A Lawlor; Graciela Muniz-Terrera; Fiona Matthews; Rachel Cooper; Arjun K Ghosh; Diana Kuh; Rebecca Hardy
Journal:  Epidemiology       Date:  2012-03       Impact factor: 4.822

Review 6.  Leptin and renal disease.

Authors:  Gunter Wolf; Sheldon Chen; Dong Cheol Han; Fuad N Ziyadeh
Journal:  Am J Kidney Dis       Date:  2002-01       Impact factor: 8.860

7.  Body mass index and the risk of development of end-stage renal disease in a screened cohort.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Kozen Kinjo; Taku Inoue; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2004-05       Impact factor: 10.612

8.  Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls.

Authors:  Jonathan A C Sterne; Ian R White; John B Carlin; Michael Spratt; Patrick Royston; Michael G Kenward; Angela M Wood; James R Carpenter
Journal:  BMJ       Date:  2009-06-29

Review 9.  Association between obesity and kidney disease: a systematic review and meta-analysis.

Authors:  Y Wang; X Chen; Y Song; B Caballero; L J Cheskin
Journal:  Kidney Int       Date:  2007-10-10       Impact factor: 10.612

10.  Cohort profile: updating the cohort profile for the MRC National Survey of Health and Development: a new clinic-based data collection for ageing research.

Authors:  Diana Kuh; Mary Pierce; Judith Adams; John Deanfield; Ulf Ekelund; Peter Friberg; Arjun K Ghosh; Nikki Harwood; Alun Hughes; Peter W Macfarlane; Gita Mishra; Denis Pellerin; Andrew Wong; Alison M Stephen; Marcus Richards; Rebecca Hardy
Journal:  Int J Epidemiol       Date:  2011-02       Impact factor: 7.196

View more
  25 in total

1.  Can childhood obesity influence later chronic kidney disease?

Authors:  Lyda Jadresic; Richard J Silverwood; Sanjay Kinra; Dorothea Nitsch
Journal:  Pediatr Nephrol       Date:  2018-11-10       Impact factor: 3.714

2.  Association of Blood Pressure Trajectories in Early Life with Subclinical Renal Damage in Middle Age.

Authors:  Wenling Zheng; Jianjun Mu; Chao Chu; Jiawen Hu; Yu Yan; Qiong Ma; Yongbo Lv; Xianjing Xu; Keke Wang; Yang Wang; Ying Deng; Bo Yan; Ruihai Yang; Jun Yang; Yong Ren; Zuyi Yuan
Journal:  J Am Soc Nephrol       Date:  2018-11-12       Impact factor: 10.121

3.  Increased body mass index may be associated with greater risk of end-stage renal disease in whites compared to blacks: A nested case-control study.

Authors:  Elvis A Akwo; Kerri L Cavanaugh; Talat Alp Ikizler; William J Blot; Loren Lipworth
Journal:  BMC Nutr       Date:  2015-11-19

4.  Glomerular hypertrophy in subjects with low nephron number: contributions of sex, body size and race.

Authors:  Victor G Puelles; Rebecca N Douglas-Denton; Monika A Zimanyi; James A Armitage; Michael D Hughson; Peter G Kerr; John F Bertram
Journal:  Nephrol Dial Transplant       Date:  2014-05-02       Impact factor: 5.992

5.  Impact of Body Mass Index on Progression of IgA Nephropathy Among Japanese Patients.

Authors:  Mamiko Shimamoto; Isao Ohsawa; Hiyori Suzuki; Atsuko Hisada; Seiji Nagamachi; Daisuke Honda; Hiroyuki Inoshita; Yoshio Shimizu; Satoshi Horikoshi; Yasuhiko Tomino
Journal:  J Clin Lab Anal       Date:  2014-08-17       Impact factor: 2.352

6.  Beginning the trajectory to ESKD in adult life: albuminuria in Australian aboriginal children and adolescents.

Authors:  Siah Kim; Petra Macaskill; Elisabeth M Hodson; Jennifer Daylight; Rita Williams; Rachael Kearns; Nicola Vukasin; David M Lyle; Jonathan C Craig
Journal:  Pediatr Nephrol       Date:  2016-06-23       Impact factor: 3.714

7.  Mid-adulthood risk factor profiles for CKD.

Authors:  Gearoid M McMahon; Sarah R Preis; Shih-Jen Hwang; Caroline S Fox
Journal:  J Am Soc Nephrol       Date:  2014-06-26       Impact factor: 10.121

8.  How Has the Age-Related Process of Overweight or Obesity Development Changed over Time? Co-ordinated Analyses of Individual Participant Data from Five United Kingdom Birth Cohorts.

Authors:  William Johnson; Leah Li; Diana Kuh; Rebecca Hardy
Journal:  PLoS Med       Date:  2015-05-19       Impact factor: 11.069

9.  Body mass index and early kidney function decline in young adults: a longitudinal analysis of the CARDIA (Coronary Artery Risk Development in Young Adults) study.

Authors:  Vanessa Grubbs; Feng Lin; Eric Vittinghoff; Michael G Shlipak; Carmen A Peralta; Nisha Bansal; David R Jacobs; David S Siscovick; Cora E Lewis; Kirsten Bibbins-Domingo
Journal:  Am J Kidney Dis       Date:  2013-12-02       Impact factor: 11.072

10.  Representativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD).

Authors:  Krishnan Bhaskaran; Harriet J Forbes; Ian Douglas; David A Leon; Liam Smeeth
Journal:  BMJ Open       Date:  2013-09-13       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.